Marketing In Biotech: Crafting The Message That Moves Science Forward

By Daniela Schardinger published on Forbes.com

Every year, thousands of biotech breakthroughs stall. Not because the science failed, but because the story did.

A survey of biotech investors found that 86% believe that fewer than half of management teams communicate effectively, directly hurting their ability to secure funding and partnerships. In other words, brilliant science is not enough. If you cannot articulate its value clearly and compellingly, discoveries may never see the light of day.

This challenge extends beyond biotech. Any complex, regulated or technical field risks speaking only to itself, while the rest of the market struggles to engage. For early-stage founders in health innovation, the cost of that gap is especially high.

After nearly two decades in biotech, advising startups, speaking at global policy tables and helping shape a $2.5 billion investment toward underserved health needs, I have seen one thing consistently hold innovators back: They underestimate how early and how often they need to communicate their value and their reason for existing.

Here are seven mindset shifts that can help you, whether you are a biotech founder or a leader in another technical industry, get heard by the people who matter most.

Read the full article on Forbes.com